Morning Overview on MSN
1 protein block slowed cancer in mice, and it’s a promising target
Researchers have identified a single protein whose absence can cripple tumors in mice, slowing their growth and in some cases ...
Using CRISPR-based technologies, the MoDeL team introduces precise genetic modifications in mice, enabling researchers to uncover how mammalian genes maintain health and contribute to disease.
A study has revealed why some patients don't respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors and identifies a new combination treatment. Publishing in Nature Immunology, ...
A study has revealed why some patients don’t respond to immune checkpoint blockade (ICB) therapy for solid cancer tumours and identifies a new combination treatment. Publishing in Nature Immunology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback